Clinical characteristic | Cases (n) | miR-135 expression | P | miR-20a expression | P |
---|---|---|---|---|---|
Gender | Â | Â | > 0.05 | Â | > 0.05 |
 M | 97 | 7.56 ± 0.57 |  | 6.56 ± 0.85 |  |
 F | 49 | 7.43 ± 0.54 |  | 6.48 ± 0.83 |  |
Age (years) | Â | Â | > 0.05 | Â | > 0.05 |
 < 60 | 88 | 7.98 ± 0.67 |  | 6.64 ± 0.76 |  |
 ≥ 60 | 58 | 8.16 ± 0.69 |  | 6.72 ± 0.81 |  |
Degree of gastric cancer progression | Â | Â | < 0.01 | Â | < 0.01 |
 Early stage | 54 | 7.96 ± 0.32 |  | 5.08 ± 0.46 |  |
 Progressive phase | 92 | 9.11 ± 0.34 |  | 7.23 ± 0.41 |  |
TNM stage | Â | Â | < 0.01 | Â | < 0.01 |
 I-II | 76 | 7.24 ± 0.26 |  | 4.93 ± 0.37 |  |
 III-IV | 70 | 9.36 ± 0.28 |  | 7.51 ± 0.42 |  |
Degrees of differentiation | Â | Â | < 0.01 | Â | < 0.01 |
 Well differentiated | 94 | 7.78 ± 0.34 |  | 5.56 ± 0.42 |  |
 Poorly differentiated | 52 | 9.36 ± 0.41 |  | 7.38 ± 0.47 |  |
Lymph node metastasis | Â | Â | < 0.01 | Â | < 0.01 |
 No | 65 | 7.43 ± 0.27 |  | 5.13 ± 0.49 |  |
 Yes | 81 | 9.27 ± 0.32 |  | 7.44 ± 0.46 |  |
Distant metastasis | Â | Â | < 0.01 | Â | < 0.01 |
 Yes | 53 | 7.51 ± 0.45 |  | 5.34 ± 0.66 |  |
 No | 93 | 9.43 ± 0.53 |  | 7.63 ± 0.72 |  |